These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10794799)

  • 1. Genetic immunotherapy for cancer.
    Ribas A; Butterfield LH; Economou JS
    Oncologist; 2000; 5(2):87-98. PubMed ID: 10794799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current developments in cancer vaccines and cellular immunotherapy.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-based strategies for the immunotherapy of cancer.
    Tüting T; Storkus WJ; Lotze MT
    J Mol Med (Berl); 1997 Jul; 75(7):478-91. PubMed ID: 9253711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA-based dendritic cell vaccines.
    Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
    Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.
    Chiang CY; Chen YJ; Wu CC; Liu SJ; Leng CH; Chen HW
    Front Immunol; 2018; 9():822. PubMed ID: 29755461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-based nanovaccines for cancer immunotherapy.
    Paulis LE; Mandal S; Kreutz M; Figdor CG
    Curr Opin Immunol; 2013 Jun; 25(3):389-95. PubMed ID: 23571027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy: new insights].
    Geissler M; Weth R
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupled for cross-presentation in tumor immunotherapy.
    Pang B; Neefjes J
    Sci Transl Med; 2010 Aug; 2(44):44ps40. PubMed ID: 20702855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen trapping by dendritic cells for antitumor therapy.
    Pal C
    Methods Mol Biol; 2014; 1139():33-40. PubMed ID: 24619668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dendritic cells and immune function in cancer].
    Chaux P
    Pathol Biol (Paris); 1995 Dec; 43(10):897-903. PubMed ID: 8786896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA pulsed dendritic cells: an approach for cancer immunotherapy.
    Garg NK; Dwivedi P; Prabha P; Tyagi RK
    Vaccine; 2013 Feb; 31(8):1141-56. PubMed ID: 23306369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA transfected dendritic cells as cancer vaccines.
    Mitchell DA; Nair SK
    Curr Opin Mol Ther; 2000 Apr; 2(2):176-81. PubMed ID: 11249639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
    Rossowska J; Pajtasz-Piasecka E
    Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer treatment by comprehensive regulation of anti-tumor immune network].
    Kawakami Y
    Nihon Rinsho; 2010 Jun; 68(6):1094-9. PubMed ID: 20535961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy of cancer: promise and reality].
    Chouaib S; El Hage F; Benlalam H; Mami-Chouaib F
    Med Sci (Paris); 2006; 22(8-9):755-9. PubMed ID: 16962052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.
    Gabitzsch ES; Tsang KY; Palena C; David JM; Fantini M; Kwilas A; Rice AE; Latchman Y; Hodge JW; Gulley JL; Madan RA; Heery CR; Balint JP; Jones FR; Schlom J
    Oncotarget; 2015 Oct; 6(31):31344-59. PubMed ID: 26374823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.
    Makkouk A; Weiner GJ
    Cancer Res; 2015 Jan; 75(1):5-10. PubMed ID: 25524899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
    Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.